11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and buprenorphine

11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid has been researched along with buprenorphine in 1 studies

Compound Research Comparison

Studies (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid)	Trials (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid)	Recent Studies (post-2010) (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid)	Studies (buprenorphine)	Trials (buprenorphine)	Recent Studies (post-2010) (buprenorphine)
304	27	103	7,273	1,223	3,826

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kriikku, P; Mariottini, C; Ojanperä, I	1

Other Studies

1 other study(ies) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and buprenorphine

Article	Year
Increase in drugs-of-abuse findings in post-mortem toxicology due to COVID-19 restrictions-First observations in Finland. Drug testing and analysis, 2021, Volume: 13, Issue:4 Topics: Amphetamine; Analgesics, Opioid; Autopsy; Buprenorphine; Cannabinoid Receptor Agonists; Central Nervous System Stimulants; COVID-19; Dronabinol; Finland; Forensic Toxicology; Harm Reduction; Humans; Illicit Drugs; Substance-Related Disorders	2021

Article

Year

Increase in drugs-of-abuse findings in post-mortem toxicology due to COVID-19 restrictions-First observations in Finland.

Drug testing and analysis, 2021, Volume: 13, Issue:4

Topics: Amphetamine; Analgesics, Opioid; Autopsy; Buprenorphine; Cannabinoid Receptor Agonists; Central Nervous System Stimulants; COVID-19; Dronabinol; Finland; Forensic Toxicology; Harm Reduction; Humans; Illicit Drugs; Substance-Related Disorders

2021